Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 3, 1994 - Issue 6
Submit an article Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Research

Meeting Highlights: Focus on new advancements in the areas of headache management, substance abuse and Alzheimer's disease: general regulatory issues: in vitro pharmacokinetics and toxicology

William E Heydorn Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, NJ, 07652, US
Pages 647-651 | Published online: 03 Mar 2008

References

  • MONDELL B, GIULIANO R: Intramuscular dihydroergo-tamine monotherapy for control of acute migraine in the office setting. Clin. Pharm. Ther. (1994) 55(2):129.
  • AHFS 94 Drug Information McEvoy GK (Ed), American Society of Hospital Pharmacists, Bethseda MD USA 1994, p 806–807.
  • POLVINO W, SCRIBERRAS D, GERTZ B, CHENG H, STEPANAVAGE M, WITTREICH J, OLAH T, EDWARDS M, MANT T: MK-462: First human experience with a novel 5-11T10 agonist Clin. Pharm. Ther. (1994) 55(4:129.
  • SOLOMON GD, PEARSON E: Sertraline in the manage-ment of headache. din. Pharm. Ther. (1994) 55(2):130.
  • AHFS 94 Drug Information McEvoy GK (Ed), AmericanSociety of Hospital Pharmacists, Bethseda, MD USA 1994, p 1406.
  • SULLIVAN JT, JOHNSON RE, TESTA MP, STITZER M, JASIN-SKI DR: Development of a method to screen for opiate withdrawal supressing drugs: Clonidine (C) effects. CBn. Pharm. Ther. (1994) 55(2):131.
  • COVI L, MONTOYA ID, HESS J, KREITER N: Double-blindcomparison of desipramine and placebo for treatment of cocaine dependence. Clin. Pharm. Ther. (1994) 55(2):132.
  • CUTLER NR, SEIFERT RD, SRAMEK JJ, SCHLEMAN MM:Safety and RBC cholinesterase activity of MDL 73,745 in healthy volunteers. Clin. Pharm. Ther. (1994) 55(2):136.
  • CUTLER NR, SRAMEK JJ, SEIFERT RD, HOURANI J, REECEPA, BOCKBRADER H, SEDMAN AJ: Safety and tolerance of the muscarinic agonist CI-979. Gun. Pharm. Ther. (1994) 55(2):174.
  • SRAMEK .11, CUTLER NR, SEIFERT RD, CONRAD JJ, WARDLETS, HURLEY DJ, THOREN LM: The safety and tolerance of xanomeline tartrate, a Ml-specific cholinergic agonist, in patients with Alzheimer's disease. Clin. Pharm. Ther. (1994) 55(2)174.
  • KAITIN K, BROWN J, LASAGNA L: 12 month safety studies:What do we learn? Clin. Pharm. Ther. (1994) 55(2):159.
  • CANTTLENA LR, MORGAN AP: Assessment of primarycultures of rat renal proximal tubule cells as a potential screening system for xenobiotic nephrotoxicity. Pharm. Ther. (1994) 55(4:181.
  • HAMMOND PB, BET II FS RP: Metals. In: Casarett and Doull's Toxicology, The Basic Science of Poisons (1980), Doull Kl.aassen CD, Amdur MO (Eds), Macmillan Publishing Co. New York, p428–435.
  • SANDE MA, MANDELL GL: Antimicrobial agents (contin-ued): The aminoglycosides. In: Goodman and Gilman 's The Pharmacological Basks of Therapeutics (1990), Gilman AG, Rail 7'W, Nies AS, Taylor P (Eds), Pergamon Press, New York p1098–1116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.